Celeris Therapeutics

Developer of an AI-driven degrader platform for drug discovery

placeGraz, Styria, Austria calendar_todayFounded 2020 groups17 employees language celeristx.com

Innovation

1 patent family — focus: Physics & computing; filing pace slowing. Cited 8 times.

YearFilings
20231

Investor mix

6 investors on record.

Investor typeCountShare
Other / undisclosed6100%
Coming soon